Malik 1998.

Methods	Allocation concealment: consecutive sealed envelopes Blinding of study: no Support: Pfizer
Participants	106 participants total Excluded: 6 Leukaemia, empirically
Interventions	Fluconazole: 400 mg/d orally Amphotericin B: 0.5 mg/kg/d iv
Outcomes	Death
Notes	Follow‐up period (days): till resolution of neutropenia Days on fluconazole: NA Days on amphotericin B: NA Support: two authors from Pfizer
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment (selection bias)	Low risk	A ‐ Adequate
Blinding (performance bias and detection bias) All outcomes	High risk